Alternative Risk Markers in Coronary Artery Disease (ARMCAD)

NCT00403351 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 665

Last updated 2020-09-02

No results posted yet for this study

Summary

Estimating the risk of future cardiovascular events such as death, stroke and myocardial infarction using traditional risk factors (such as age, gender, smoking, diabetes, hyperlipidaemia and hypertension) is well accepted in patients with and without existing cardiovascular disease. These estimates are based on a number of robust observational studies, including the original Framingham study. While these methods apply reasonably well on a population level their application to the individual patients is not always straightforward. In addition, risk charts, such as those published by the Joint British Societies and American Heart Association, may underestimate risk in certain groups, notably diabetics and patients of Indo-Asian background, whilst overestimating risk in others (by as much as 50% in some studies).

Conditions

  • Coronary Artery Disease

Sponsors & Collaborators

  • Royal Brompton & Harefield NHS Foundation Trust

    collaborator OTHER
  • IM Medical Ltd, Melbourne

    collaborator UNKNOWN
  • Monash University

    lead OTHER

Principal Investigators

  • Dipak Kotecha, MB ChB PhD · Monash University, Royal Brompton Hospital & University of Birmingham

  • David Eccleston, MBBS FRACP · Monash University and Northern Hospital

  • Henry Krum, Professor · Alfred Hospital / Monash University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2008-06-30
Completion
2016-05-31

Countries

  • Australia

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00403351 on ClinicalTrials.gov